000			01925 a2200565 4500
005			20250518071004.0
264		0	_c20200603
008			202006s 0 0 eng d
022			_a1573-7241
024	7		_a10.1007/s10557-019-06909-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aLuzum, Jasmine A
245	0	0	_aAssociation of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure. _h[electronic resource]
260			_bCardiovascular drugs and therapy _c12 2019
300			_a693-700 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdrenergic beta-Antagonists _xtherapeutic use
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAngiotensin Receptor Antagonists _xtherapeutic use
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aCardiovascular Agents _xadverse effects
650	0	4	_aFemale
650	0	4	_aGenetic Association Studies
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aHeart Failure _xdiagnosis
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPhenotype
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aProspective Studies
650	0	4	_aProtein Kinase C-alpha _xgenetics
650	0	4	_aRegistries
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aTing, Christopher
700	1		_aPeterson, Edward L
700	1		_aGui, Hongsheng
700	1		_aShugg, Tyler
700	1		_aWilliams, L Keoki
700	1		_aLi, Liang
700	1		_aSadee, Wolfgang
700	1		_aWang, Danxin
700	1		_aLanfear, David E
773	0		_tCardiovascular drugs and therapy _gvol. 33 _gno. 6 _gp. 693-700
856	4	0	_uhttps://doi.org/10.1007/s10557-019-06909-6 _zAvailable from publisher's website
999			_c30314516 _d30314516